 |
dimethyl sulfoxide |
|---|---|
| Trade Name | |
| Orphan Indication | For use in combination with antimicrobial drugs for the treatment of drug resistant tuberculosis |
| USA Market Approval | USA |
| USA Designation Date | 2008-05-09 00:00:00 |
| Sponsor | Abela Pharmaceuticals, Inc.;21581 Midcrest Drive;Lake Forest, California, 92630 |
